The one therapy readily available for individuals with leprechaunism to this point is recombinant IGF1, aiming to forestall compensatory hyperinsulinemia (23). IGF has concerning the six% on the glucose-decreasing action effect of insulin and has a similar construction to it, thus it is ready to bind to insulin receptors triggering peripheral gluco